Estudo randomizado | Em pacientes imunocomprometidos críticos com insuficiência respiratória aguda, os desfechos foram similares com o uso de oxigênio nasal de alto fluxo vs. alternância com ventilação não invasiva.

High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial – The Lancet Respiratory Medicine (necessário cadastro gratuito)

Comentário no Twitter

NEW Research—In critically ill immunocompromised patients with acute respiratory failure, the mortality rate did not differ between HFNO alone and NIV alternating with HFNO

FLORALI-IM study from Rémi Coudroy & co https://t.co/xSJfQ9yTCt

Presented today at @ISICEM #ISICEM2022 pic.twitter.com/ooHnRcVnFV

— The Lancet Respiratory Medicine (@LancetRespirMed) March 22, 2022